Involvement of STAT3, NF-ΚB and associated downstream molecules before and after the onset of urethane induced lung tumors in mouse

Environmental Toxicology and Pharmacology

Volumn 34, Issue 2, 2012, Pages 502-511

  Pandey, Manuraj ^a   Gupta, Krishna P ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Chemoprevention; Inositol hexaphosphate; Lung tumor; NF B; STAT3; Urethane

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PHYTIC ACID; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; URETHAN; CARCINOGEN; PTGS2 PROTEIN, MOUSE; BETA ACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; LUNG ADENOMA; LUNG CANCER; LUNG CARCINOGENESIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR VOLUME; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; DISEASE ASSOCIATION; DRUG SENSITIVITY; TREATMENT RESPONSE; TUMOR GROWTH;

MUS;

ANIMALS; CARCINOGENS; CYCLIN D1; CYCLOOXYGENASE 2; FEMALE; INTERLEUKIN-6; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NF-KAPPA B; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; URETHANE;

EID: 84863732724     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.06.007     Document Type: Article

References (23)

1. Aggarwal, B.B., Shishodia, S., Sandur, S.K., Pandey, M.K., Sethi, G., 2006. Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72, 1605-1621.
2. Bauer, A.K., Dwyer-Nield, L.D., Malkinson, A.M., 2000. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) content in mouse lung tumors. Carcinogenesis 21, 543-550.
3. Dolcet, X., Llobet, D., Pallares, J., Matias-Guiu, X., 2005. NF-?B in development and progression of human cancer. Virchows Arch. 446, 475-482.
4. Gao, S.P., Mark, K.G., Leslie, K., Pao, W., Motoi, N., Gerald, W.L., Travis, W.D., Bornmann, W., Veach, D., Clarkson, B., Bromberg, J.F., 2007. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J. Clin. Invest. 117, 3846-3856.
5. Gordon, T., Bosland, M., 2009. Strain-dependent differences in susceptibility to lung cancer in inbred mice exposed to mainstream cigarette smoke. Cancer Lett. 275, 213-220.
6. Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., Karin, M., 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103-113.
7. Gupta, K.P., Singh, J., Bharathi, R., 2003. Suppression of DMBA induced mouse skin tumor development by inositol hexaphosphate and its mode of action. Nutr. Cancer 46, 66-72.
8. Herbst, R.S., Heymach, J.V., Lippman, S.M., 2008. Lung cancer. N. Engl. J. Med. 359, 1367-1380.
9. Hong, D.S., Angelo, L.S., Kurzrock, R., 2007. Interleukin-6 and its receptor in cancer, implications for translational therapeutics. Cancer 110, 1911-1928.
10. Jarnicki, A., Putoczki, T., Ernst, M.R., 2010. STAT3: linking inflammation to epithelial cancer - more than a gut feeling? Cell Div. 5, 14.
11. Kishimoto, T., 2005. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23, 1-21.
12. Kisley, L.R., Barrett, B.S., Dwyer-Nield, L.D., Bauer, A.K., Thompson, D.C., Malkinson, A.M., 2002. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis 23, 1653-1660.
13. Mantovani, A., Allavena, P., Sica, A., Balkwill, F., 2008. Cancer-related inflammation. Nature 454, 436-444.
14. Meylan, E., Dooley, A.L., Feldser, D.M., Shen, L., Turk, E., Ouyang, C., Jacks, T., 2009. Requirement for NF-?B signalling in a mouse model of lung adenocarcinoma. Nature 462, 104-107.
15. Nishikori, M., 2005. Classical and alternative Nf?β activation pathways and their roles in lymphoid malignancies. J. Clin. Exp. Hematopathol. 45, 15-24.
16. Raina, K., Rajamanickam, S., Singh, R.P., Agarwal, R., 2008. Chemopreventive efficacy of inositol hexaphosphate againstprostate tumor growth and progression in tramp mice. Clin. Cancer Res. 14, 3177-3184.
17. Schafer, Z.T., Brugge, J.S., 2007. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117, 3660-3663.
18. Stathopoulos, G.T., Sherrill, T.P., Cheng, D.S., Scoggins, R.M., Han, W., Polosukhin, V.V., Connelly, L., Yull, F.E., Fingleton, B., Blackwell, T.S., 2007. Epithelial NF-?B activation promotes urethane-induced lung carcinogenesis. PNAS 104, 18514-18519.
19. Vucenik, I., Passaniti, A., Vitolo, M.I., Tantivejkul, K., Eggleton, P., Shamsuddin, A.K.M., 2004. Anti angiogenic activity of inositol hexaphosphate. Carcinogenesis 25, 2115-2123.
20. Wang, I.C., Meliton, L., Ren, X., Zhang, Y., Balli, D., Snyder, J., Whitsett, J.A., Kalinichenko, V.V., Kalin, T.V., 2009. Deletion of forkhead box m1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis. PLoS One 4, 1-13.
21. Yan, X., Xiao, C.W., Sun, M., Tsang, B.K., Gibb, W., 2002. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1b. Biol. Reprod. 66, 1667-1671.
22. Yang, J., Liao, X., Agarwal, M.K., Barnes, L., Auron, P.E., Stark, G.R., 2007. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF-kB. Genes Dev. 21, 1396-1408.
23. Yue, P., Turkson, J., 2009. Targeting STAT3 in cancer: how successful are we? Expert Opin. Investig. Drugs 18, 45-56.